+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Eczema Drug"

Atopic Dermatitis Drugs: Global Strategic Business Report - Product Thumbnail Image

Atopic Dermatitis Drugs: Global Strategic Business Report

  • Report
  • December 2023
  • 179 Pages
  • Global
From
Atopic Dermatitis - Competitive Landscape, 2023 - Product Thumbnail Image

Atopic Dermatitis - Competitive Landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
Global Atopic Dermatitis Drugs Market 2023-2027 - Product Thumbnail Image

Global Atopic Dermatitis Drugs Market 2023-2027

  • Report
  • April 2023
  • 162 Pages
  • Global
From
EUCRISA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EUCRISA Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
DUPIXENT Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DUPIXENT Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
TOCTINO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TOCTINO Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
From
From
Loading Indicator

The Eczema Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Eczema drugs are used to treat the symptoms of eczema, a chronic skin condition characterized by red, itchy, and inflamed skin. These drugs are typically topical creams, ointments, and lotions, and may contain corticosteroids, calcineurin inhibitors, and other active ingredients. In addition to treating the symptoms of eczema, these drugs may also help to reduce the risk of infection and improve the overall quality of life for those affected by the condition. Some companies in the Eczema Drug market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Show Less Read more